{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:44:38Z","timestamp":1760013878934,"version":"3.37.3"},"reference-count":115,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["#111554531478","#111551928905","#111554531400"],"award-info":[{"award-number":["#111554531478","#111551928905","#111554531400"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2016.00304","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T08:39:00Z","timestamp":1482395940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America"],"prefix":"10.3389","volume":"8","author":[{"given":"Gloria Patricia","family":"Cardona-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000051175","article-title":"The frequency of inherited disorders database: Prevalence of Huntington disease","volume":"4","author":"Al-Jader","year":"2001","journal-title":"Community Genet."},{"year":"2016","author":"Alzheimer\u2019s association","key":"B201"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2174\/156720512803569055","article-title":"The animal models of dementia and Alzheimer\u2019s disease for pre-clinical testing and clinical translation","volume":"9","author":"Anand","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/wnl.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/j.1582-4934.2010.01135.x","article-title":"Neuroprotection in acute ischemic stroke\u2014current status","volume":"14","author":"Auriel","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00023210-200923040-00003","article-title":"Novel regimens and delivery systems in the pharmacological treatment of Alzheimer\u2019s disease","volume":"23","author":"Bassil","year":"2009","journal-title":"CNS Drugs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/hipo.22219","article-title":"Neuronal and glial alterations, increased anxiety and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer\u2019s disease","volume":"24","author":"Beauquis","year":"2014","journal-title":"Hippocampus"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0162-2","article-title":"Neuroprotection induced by transplanted CDK5 knockdown astrocytes in global cerebral ischemic rats","author":"Becerra-Calixto","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1037\/a0023167","article-title":"Rock inhibition prevent hyperphosphorylation of Tau and p25\/CDK5 increase after global cerebral ischemia","volume":"125","author":"Castro-Alvarez","year":"2011","journal-title":"Behav. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/jnr.23576","article-title":"Cyclin-Dependent kinase 5 targeting prevents \u03b2-Amyloid aggregation involving glycogen synthase kinase 3\u03b2 and phosphatases","volume":"93","author":"Castro-Alvarez","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnagi.2014.00243","article-title":"Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer\u2019s mice","volume":"6","author":"Castro-Alvarez","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7705\/biomedica.v33i2.830","article-title":"Injury markers in two models of cerebral ischemia","volume":"33","author":"C\u00e9spedes","year":"2013","journal-title":"Biomedica"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1002\/jnr.22511","article-title":"p120 catenin\/\u03b1 N-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia","volume":"88","author":"C\u00e9spedes-Rubio","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.wad.0000155065.31561.0a","article-title":"Neuropathology lessons in vascular dementia","volume":"19","author":"Chui","year":"2005","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine\u2014searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1471-4159.2011.07458.x","article-title":"Clinical trials in Alzheimer\u2019s disease\u201d: immunotherapy approaches","volume":"120","author":"Delrieu","year":"2012","journal-title":"J. Neurochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0006-8993(95)00417-o","article-title":"Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study","volume":"684","author":"Dewar","year":"1995","journal-title":"Brain Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7150\/ijms.7634","article-title":"Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage","volume":"11","author":"Dong","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1878-5085-4-7","article-title":"Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine","volume":"4","author":"Drucker","year":"2013","journal-title":"EPMA J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pbb.2007.04.015","article-title":"Acute ischemic stroke: overview of major experimental rodent models, pathophysiology and therapy of focal cerebral ischemia","volume":"87","author":"Durukan","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/jcbfm.1994.69","article-title":"Alterations in \u03c4 immunostaining in the rat hippocampus following transient cerebral ischemia","volume":"14","author":"Geddes","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0006-8993(92)90634-l","article-title":"Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer\u2019s brain","volume":"569","author":"Gomez-Ramos","year":"1992","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1590\/s1980-57642014dn84000002","article-title":"Building capacity for dementia care in latin america and the caribbean","volume":"8","author":"Gonzalez","year":"2014","journal-title":"Dement. Neuropsychol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuint.2010.08.014","article-title":"Rac1 activity changes are associated with neuronal pathology and spatial memory long-term recovery after global cerebral ischemia","volume":"57","author":"Guti\u00e9rrez-Vargas","year":"2010","journal-title":"Neurochem Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-015-0472-6","article-title":"Perspective of synaptic protection after post-infarction treatment with statins","volume":"13","author":"Guti\u00e9rrez-Vargas","year":"2015a","journal-title":"J. Transl. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/jcbfm.2015.150","article-title":"CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia","volume":"35","author":"Guti\u00e9rrez-Vargas","year":"2015b","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x16662476","article-title":"Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity","author":"Guti\u00e9rrez-Vargas","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/jnr.23426","article-title":"GluN2B N-methyl-D-aspartic acid receptor subunit mediates atorvastatin-Induced neuroprotection after focal cerebral ischemia","volume":"92","author":"Guti\u00e9rrez-Vargas","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"B35","first-page":"U2450","article-title":"Improving care to stroke patients: adding an acute stroke unit helps","volume":"120","author":"Hanger","year":"2007","journal-title":"N Z Med. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.bbadis.2015.12.009","article-title":"Vascular cognitive impairment: modeling a critical neurologic disease in vitro and in vivo","volume":"1862","author":"Helman","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1096\/fj.12-212118","article-title":"Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer\u2019s disease","volume":"27","author":"Ho","year":"2013","journal-title":"FASEB J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0304-3940(00)01009-0","article-title":"Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?","volume":"284","author":"Ikeda","year":"2000","journal-title":"Neurosci. Lett."},{"article-title":"La demencia en Am\u00e9rica: El coste y la prevalencia del Alzheimer y otros tipos de demencia","year":"2013","author":"Informe ADI\/Bupa","key":"B1"},{"key":"B40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s0304-3940(96)12856-1","article-title":"Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury","volume":"213","author":"Irving","year":"1996","journal-title":"Neurosci. Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1471-4159.2010.06958.x","article-title":"Experimental models of vascular dementia and vascular cognitive impairment: a systematic review","volume":"115","author":"Jiwa","year":"2010","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0197-4580(00)00125-1","article-title":"The role of cerebral ischemia in Alzheimer\u2019s disease","volume":"21","author":"Kalaria","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B43","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management and risk factors","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nn936","article-title":"NMDA receptor pathways as drug targets","volume":"5","author":"Kemp","year":"2002","journal-title":"Nat. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0014-5793(93)80723-8","article-title":"A cdc2-related kinase PSSALRE\/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule","volume":"335","author":"Kobayashi","year":"1993","journal-title":"FEBS Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.fbp.2010.04.008","article-title":"A review of the antioxidant potential of medicinal plant species","volume":"89","author":"Krishnaiah","year":"2010","journal-title":"Food Bioproducts Process."},{"key":"B48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00401-005-1090-9","article-title":"Microtubule-associated protein 2 (MAP2)\u2014a promising approach to diagnosis of forensic types of hypoxia-ischemia","volume":"110","author":"K\u00fchn","year":"2005","journal-title":"Acta Neuropathol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.112.196147","article-title":"Proatherogenic macrophage activities are targeted by the flavonoid quercetin","volume":"343","author":"Lara-Guzman","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/s1474-4422(07)70003-0","article-title":"Stroke epidemiology, prevention and management strategies at a regional level: latin america and the caribbean","volume":"6","author":"Lavados","year":"2007","journal-title":"Lancet Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00701-010-0889-x","article-title":"Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats","volume":"153","author":"Lee","year":"2011","journal-title":"Acta Neurochir. (Wien)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2016.03.003","article-title":"CSF biomarkers in neurodegenerative and vascular dementias","volume":"138\u2013140","author":"Llorens","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/STROKEAHA.116.012066","article-title":"Vascular contributions to cognitive impairment and dementia: topical review of animal models","volume":"47","author":"Madigan","year":"2016","journal-title":"Stroke"},{"key":"B54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2001-1326-3-10","article-title":"Managing the potential and pitfalls during clinical translation of emerging stem cell therapies","volume":"3","author":"Main","year":"2014","journal-title":"Clin. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer\u2019s disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"0271678X15615132","DOI":"10.1177\/0271678x15615132","article-title":"Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer\u2019s disease","volume":"9","author":"Martino Adami","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4172\/2329-6488.1000213","article-title":"Side effects of approved antidementives","volume":"21","author":"Mimica","year":"2009","journal-title":"Psychiatr. Danub."},{"key":"B59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1567202611666140408105333","article-title":"The vascular component of Alzheimer\u2019s disease","volume":"11","author":"Muresanu","year":"2014","journal-title":"Curr. Neurovasc. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1385\/1-59259-661-4:253","article-title":"An update on treatment and prevention strategies for Alzheimer\u2019s disease","volume":"9","author":"Neugroschl","year":"2009","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s1474-4422(12)70144-8","article-title":"Colombia at the centre of preclinical AD research","volume":"11","author":"Neurology","year":"2012","journal-title":"Lancet Neurol."},{"article-title":"The dementias: hope through research: risk factors for dementia","year":"2016","author":"NIH","key":"B63"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0142267","DOI":"10.1371\/journal.pone.0142267","article-title":"Chronic microdose lithium treatment prevented memory loss and neurohistopathological changes in a transgenic mouse model of Alzheimer\u2019s disease","volume":"10","author":"Nunes","year":"2015","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"B67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"crossref","first-page":"23512","DOI":"10.1016\/S0021-9258(19)49492-1","article-title":"Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer\u2019s paired helical filaments","volume":"268","author":"Paudel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/00004647-199611000-00013","article-title":"Microtubular proteolysis in focal cerebral ischemia","volume":"16","author":"Pettigrew","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fncel.2015.00498","article-title":"\u03b2-secretase 1\u2019s targeting reduces hyperphosphorilated tau, implying autophagy actors in 3xTg-AD mice","volume":"9","author":"Piedrahita","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1523\/JNEUROSCI.3637-10.2010","article-title":"Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer\u2019s mice","volume":"30","author":"Piedrahita","year":"2010","journal-title":"J. Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/1567202043361839","article-title":"From brain ischemia-reperfusion injury to possible sporadic Alzheimer\u2019s disease","volume":"1","author":"Pluta","year":"2004","journal-title":"Curr. Neurovasc. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fncel.2014.00231","article-title":"Protection after stroke: celular effectors of neurovascular unit integrity","volume":"8","author":"Posada-Duque","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/jnc.13127","article-title":"p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing","volume":"134","author":"Posada-Duque","year":"2015a","journal-title":"J. Neurochem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mcn.2015.07.001","article-title":"CDK5 knockdown in astrocytes provide neuroprotection as a trophic source via Rac1","volume":"68","author":"Posada-Duque","year":"2015b","journal-title":"Mol. Cell. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.14711\/thesis-b1029261","article-title":"CDK5 downregulation enhances synaptic plasticity","author":"Posada-Duque","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14800\/ttnd.434","article-title":"Blood biomarkers in a mouse model of CADASIL","volume":"1644","author":"Primo","year":"2016","journal-title":"Brain Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI200317522","article-title":"Neurodegeneration: what is it and where are we?","volume":"111","author":"Przedborski","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2014.3618","article-title":"Implementing a mobile stroke unit program in the United States: why, how and how much?","volume":"72","author":"Rajan","year":"2015","journal-title":"JAMA Neurol."},{"key":"B81","first-page":"900","article-title":"Emergency medical care in developing countries is it worthwhile?","volume":"80","author":"Razzak","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"B82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"Lancet Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"908915","DOI":"10.1155\/2014\/908915","article-title":"Global epidemiology of dementia: Alzheimer\u2019s and vascular types","volume":"2014","author":"Rizzi","year":"2014","journal-title":"Biomed Res. Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/SHK.0b013e31827f565b","article-title":"Nitric oxide donor agents for the treatment of ischemia\/reperfusion injury in human subjects: a systematic review","volume":"39","author":"Roberts","year":"2013","journal-title":"Shock"},{"key":"B86","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3233\/JAD-2010-1262","article-title":"Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Rojo","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2004.09.016","article-title":"Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia","volume":"226","author":"Rom\u00e1n","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice","volume":"93","author":"Sabogal-Gu\u00e1queta","year":"2015","journal-title":"Neuropharmacology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuropharm.2015.11.002","article-title":"Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer\u2019s mice","volume":"102","author":"Sabogal-Gu\u00e1queta","year":"2016","journal-title":"Neuropharmacology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.4103\/1673-5374.165208","article-title":"Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology","volume":"10","author":"Sandu","year":"2015","journal-title":"Neural Regen. Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","article-title":"Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice","volume":"26","author":"Schiavon","year":"2014","journal-title":"Neurotox. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/ncpneuro0294","article-title":"Vascular cognitive impairment","volume":"2","author":"Selnes","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1471-4159.2005.03582.x","article-title":"Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms","volume":"96","author":"Shi","year":"2006","journal-title":"J. Neurochem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1432-1033.1993.tb18025.x","article-title":"Strategies of antioxidant defense","volume":"215","author":"Sies","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1590\/0004-282X20150083","article-title":"Memory deficit associated with increased brain proinflammatory cytokine levels and neurodegeneration in acute ischemic stroke","volume":"73","author":"Silva","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease","volume":"11","author":"Snyder","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B97","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1138\/2001032","article-title":"Acetylcholinesterase\u2013new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt4","article-title":"Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)","volume":"1","author":"Stephan","year":"2009","journal-title":"Alzheimers Res. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.lfs.2013.09.005","article-title":"Quercetin glucosides promote ischemia-induced angiogenesis, but do not promote tumor growth","volume":"93","author":"Sumi","year":"2013","journal-title":"Life Sci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.5692\/clinicalneurol.51.1160","article-title":"Antibody therapy for Alzheimer\u2019s disease","volume":"51","author":"Tabira","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/01.str.26.11.2145","article-title":"Widespread appearance of Alz-50 immunoreactive neurons in the human brain with cerebral infarction","volume":"26","author":"Uchihara","year":"1995","journal-title":"Stroke"},{"key":"B101","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0304-3940(00)01103-4","article-title":"Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction","volume":"286","author":"Uchihara","year":"2000","journal-title":"Neurosci. Lett."},{"key":"B102","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/jnc.13697","article-title":"p120-catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer\u2019s disease","volume":"138","author":"Uribe-Arias","year":"2016","journal-title":"J. Neurochem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbr.2013.05.043","article-title":"Neurohistological and behavioral changes following the four-vessel occlusion\/internal carotid artery model of chronic cerebral hypoperfusion comparison between normotensive and spontaneously hypertensive rats","volume":"252","author":"Val\u00e9rio Romanini","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1476-5381.2011.01299.x","article-title":"Animal models in the drug discovery pipeline for Alzheimer\u2019s disease","volume":"164","author":"Van Dam","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1523\/JNEUROSCI.0862-13.2014","article-title":"in vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive d\u00e9ficits in an Alzheimer\u2019s disease model","volume":"34","author":"Vargas","year":"2014","journal-title":"J. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","article-title":"Models and mechanisms of vascular dementia","volume":"272","author":"Venkat","year":"2015","journal-title":"Exp. Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","article-title":"Stroke, vascular dementia and Alzheimer\u2019s disease: molecular links","volume":"54","author":"Vijayan","year":"2016","journal-title":"J. Alzheiemrs Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fncel.2016.00260","article-title":"BACE1 RNAi restores the composition of phosphatidylethanolamine-derivates related to memory improvement in aged 3xTg-AD mice","volume":"10","author":"Villamil-Ortiz","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnagi.2015.00084","article-title":"Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer\u2019s disease animal models","volume":"7","author":"Villamil-Ortiz","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/STROKEAHA.115.009010","article-title":"Role of vascular disease in alzheimer-like progressive cognitive impairment","volume":"47","author":"Viswanathan","year":"2016","journal-title":"Stroke"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1212\/01.wnl.0000140490.22251.b6","article-title":"Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke","volume":"63","author":"Wen","year":"2004","journal-title":"Neurology"},{"article-title":"Dementia","year":"2016","author":"WHO","key":"B111"},{"key":"B112","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2014.01.075","article-title":"Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents","volume":"100","author":"Yang","year":"2014","journal-title":"Life Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/fbp.0b013e3282da278d","article-title":"Anti-dementia drugs and hippocampal-dependent memory in rodents","volume":"18","author":"Yuede","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0197-4580(02)00066-0","article-title":"The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy","volume":"24","author":"Zekry","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B115","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jcb.22408","article-title":"Tau as a potential novel therapeutic target in ischemic stroke","volume":"109","author":"Zheng","year":"2010","journal-title":"J. Cell. Biochem."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T19:14:44Z","timestamp":1658258084000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":115,"URL":"https:\/\/doi.org\/10.3389\/fnagi.2016.00304","relation":{},"ISSN":["1663-4365"],"issn-type":[{"type":"electronic","value":"1663-4365"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}